Zynex Inc. (ZYXI) recently announced the Food and Drug Administration (“FDA”) clearance of its new TensWave device, which aligns perfectly with Zynex’s commitment to providing comprehensive pain management solutions. Following the announcement, shares of Zynex rose 0.4% till yesterday.The latest FDA clearance strengthens Zynex's pain management product portfolio and supports the ongoing mission to improve patient outcomes through its innovative medical technology.About Zynex’s TensWave DeviceTensWave offers ...